Itamar Medical Ltd - ADR
ITMR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$506.61M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $506.61 Million |
|---|---|
| Enterprise Value | $506.80 Million |
| Earnings per Share | $-0.79 |
| Beta | 0.54 |
| Outstanding Shares | 16,411,000 |
Return
| Return on Equity | -25.34% |
|---|---|
| Return on Assets | -18.30% |
| Return on Invested Capital | -21.58% |
Valuation & Multiples
| P/E Ratio | -39.08 |
|---|---|
| PEG | -20.64 |
| Price to Sales | 15.44 |
| Price to Book Ratio | 7.72 |
| Enterprise Value to Revenue | 11.02 |
| Enterprise Value to EBIT | -29.16 |
| Enterprise Value to Net Income | -28 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Itamar Medical Ltd.
CEO: Gilad Glick
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The ...